3D Bioprinting: Transforming The Future of Healthcare Sector (Technical Insights)

Research Scope

Research Methodology

Key Findings–3DBP will Significantly Impact the Development of Artificial Organs in the Healthcare Sector

What are the Big Shifts Expected in the Healthcare Sector by 2020?

1. Medical Devices: Mind-Machine Interface

2. Medical Devices: Continuous Patient Monitoring (CPM)

3. Medical Devices: Mobile Health

4. Life Sciences: Artificial Organs

5. Pharmaceuticals: Smart Pills

6. Diagnostics: Optical Imaging

7. Diagnostics: Advanced Visualization

What is the Role of Manufacturing Innovations in Healthcare?

How Can 3DBP Change the Paradigm of the Healthcare Sector?

Is 3DBP Ready for Commercialization?

How Will 3DBP Evolve in the Healthcare Sector?

Movers and Shakers in 3DBP

Significance of 3DBP for Soft Tissue Printing

Impact and Opportunity Landscape of 3DBP for Soft Tissue Printing

Significance of 3DBP for Hard Tissue Printing

Impact and Opportunity Landscape of 3DBP for hard Tissue Printing

Significance of 3DBP for Organ Printing

Impact and Opportunity Landscape of 3DBP for Organ Printing

Evaluation Metrics to Assess the Degree of Transformation Introduced by 3DBP in Healthcare

Framework to Assess the Degree of Transformation Introduced by 3DBP in Healthcare

Profiles of Innovators

Printing of Complicated Organs, Exploring Newer Materials and Expanding Application Base Attracts Funding

Patent Trends–Increase in Patent Publishing

Region-wise Development Efforts and Best Practices to Create and Capture Value

Strategic Insights

Key Patents

Key Patents (Continued)

Legal Disclaimer

Who is Frost & Sullivan

What Makes Us Unique

TEAM Methodology

Our Global Footprint 40+ Offices